Clinical trial

An Efficacy and Safety Study of Paliperidone Extended-Release (ER) Tablets in Participants With Schizophrenia

NCT00566631

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2007-07-01

PhasePHASE3

Study timeline

Study start (unknown)2007-07-01Date precision: month

Registry last updated2013-08-02

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Schizophreniaunresolved

Interventions

PaliperidoneDRUG · verified · RxNorm: paliperidone

Sponsors & collaborators

Janssen-Cilag International NVlead sponsor

Mapped research locations

BucharestRomania1 LodzPoland1 MünchenGermany1 LublinPoland1 MainzGermany1 Ramat GanIsrael1 Cluj-NapocaRomania1 BonnGermany1 ZagrebCroatia1 MannheimGermany1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00566631 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.